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3 Lesion groups, the groups smoking or not, the SYNTAX score, collateral
circulation between grouping and hierarchical, the lever of CEACAM-1 pro-
tein, MMP-9 protein had no statistical difference.
4 In coronary heart disease (CHD) in serum did not detect the expression of
MMP-7.
Conclusions: the level of serum CEACAM-1 in patients with acute myocardial
infarction was clearly higher than normal coronary angiography, SAP group, UAP
group; This may suggest the level of CEACAM-1 associated with plaque instability
and thrombosis of regulating; Patients , who are Suffering from disease of Coronary
heart disease (CHD) with type 2 diabetes , their levels of serum CEACAM-1 was
clearly higher than other groups , this suggest the serum CEACAM-1 concentration
may be a reference factor as follow: coronary blood vessels in multivessel lesions
and diffuse lesion, and the increase in the incidence of cardiovascular disease.
CEACAM-1 might be of potential relevance as a clinically diagnostic tool and
therapeutic target.
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Infarction
Zhou Xin, Shan Zeng, Wen-Jie Ji, Xin-Lin Liu, Zhao-Zeng Guo, Jun-Xiang Liu,
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Objectives: To investigate the relationships between admission monocyte subsets and
early cardiovascular outcomes in patients with ST-elevation myocardial infarction
(STEMI) undergoing primary coronary interventions (PCI).
Methods: Flow cytometry (FCM) analysis of monocyte subsets was carried out upon
admission in 100 consecutive STEMI patients treated with PCI. Major adverse car-
diovascular events (MACE) were prospectively analyzed.
Results: Compared with stable CHD patients (n¼35), a reverse relationship between
monocyte count [increases in total monocyte counts, both determined by blood
routine test (RT) and FCM, as well as in CD14++CD16- monocytes; all P<0.001]
and lymphocyte count (decreased, P<0.001) was observed in STEMI patients.
During a 30-day follow-up, 7 STEMI patients experienced MACE. Kaplan-Meier
analysis demonstrated that an increased ratio of FCM-measured monocyte to
lymphocyte count (MTLR, P¼0.006) as well as an increased CD14++CD16– MTLR
(P¼0.006), but not CD14++CD16+ and CD14+CD16++ MTLRs, predicted MACE.
In multivariable analysis, FCM-measured MTLR (per 0.1 increase, HR: 1.451; 95%
CI: 1.018 to 2.068; P¼0.039) and CD14++CD16– MTLR (per 0.1 increase, HR:
1.533; 95% CI: 1.016 to 2.312; P¼0.042) independently predicted MACE. The
prognostic value was not observed in RT-measured monocyte count. Bland-Altman
plot and correlation analyses revealed a poor agreement between FCM- and RT-
measured monocyte count in STEMI patients (r¼0.578). In contrast, the correlation
of the monocyte count by these two methods was signiﬁcantly improved in stable
CHD patients (r¼0.861).
Conclusions: Acute STEMI-induced monocyte mobilization yields poor agreement
between RT- and FCM-measured admission monocyte counts. FCM-measured
admission MTLR and CD14++CD16–MTLR independently predict 30-day MACE in
STEMI patients treated with primary PCI.
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The short-term effects of pre-treatment of statins on reperfusion and short-term
clinical prognosis after percutaneous coronary intervention in patients with non
ST-segment elevation acute coronary syndrome
Chao Ding
Bethune International Peace Hospital
Objectives: To evaluate the effect of pre-treatment with statin on the reperfusion and
short-term clinical prognosis in patients with non ST-segment elevation acute
coronary syndrome (NSTE-ACS) who underwent successful primary percutanous
coronary intervention (PCI).
Methods: A total of 162 consecutive high –risk NSTE-ACS patients undergoing PCI
received simvastatin for 3 days before PCI. The patients were randomly divided into
two groups: standard statin group (20 mg simvastatin, n ¼ 81) and intensive statin
group (80 mg simvastatin, n ¼ 81). The difference of TIMI and myocardial blush
grade (MBG) of target arteries before and after PCI, serum leval of CK-MB at 24h,
LVEFand the incidence of main adverse cardiac events (MACE) at 30d follow-up
were examined in the 2 groups.
Results: The percentage of TIMI grade 2-3 ﬂow and MBG 2-3 perfusion were
signiﬁcantly higher in intensive statin group than that in standard statin group before
PCI (P< 0.05).The TIMI grade 3 ﬂow in intensive statin group showed similar result
to that in standard statin group after PCI, but the percentage of MBG 2-3 perfusion in
intensive statin group was signiﬁcantly higher than that in standard statin group
(P< 0.05).The incidence of increased CK-MB in intensive statin group was signiﬁ-
cantly lower than that in standard statin group ( P< 0.050.05).The LVEF in intensive
statin group was higher than that in standard statin group (P<0.05).It also showed
lower incidence of MACE (P<0.05) in intensive statin group than that in standard
statin group during 30 d after PCI.C134 JACC Vol 64/16/Suppl C j October 16–1Conclusions: Pre-treatment with high-dose statin for 3 days before PCI could improve
the coronary ﬂow, myocardial perfusion and heart function, attenuate the risk of
MACE during 30 d after PCI in high –risk NSTE-ACS patients.
GW25-e3538
Determinants and Prognosis of Spontaneous Coronary Reperfusion in ST-
segment Elevation Myocardial Infarction
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Objectives: Angiographic spontaneous reperfusion (SR) was deﬁned as Thrombolysis
in Myocardial Infarction (TIMI) grade ﬂow 3 assessed by angiography before pri-
mary-PCI in the culprit vessel. However, determinants of SR and its impact on the
clinical outcomes are not clear.
Methods: Consecutive STEMI patients who received emergency coronary angi-
ography from January 2009 to August 2010 in our single center were included in
this study. All patients were divided into SR group (TIMI 3 grade) and non-SR
group (TIMI 0w2 grade) according to the results of the emergency coronary
angiography. Clinical and angiographic features were analyzed to explore the de-
terminants of SR. Long-term follow-up was analyzed between patients in SR group
and NSR group.
Results: Among 207 patients, a total of 38 (18.4%) patients met the criteria of SR.
The platelet (266.6466.91 x109/L vs 235.0467.59 x109/L, P¼0.012), blood level
of uric acid (298.0374.46mmol/L vs 334.2597.82mmol/L,P¼0.039) and glucose
(6.042.75 mmol/L vs 7.613.06 mmol/L, P¼0.005) levels were statistically
different between SR group and non-SR group. Multiple factors analysis showed
that the platelet (P¼0.010), blood glucose (OR¼0.750, 95% CI 0.622-0.903,
P¼0.003) and uric acid (OR¼0.993, 95% CI 0.987-0.998, P¼0.011) were inde-
pendent predictors for SR. The culprit lesions were more distal in SR group than
those in the non SR group (OR¼0.107, 95% CI 0.029-0.393, P¼0.001).Left anterior
descending branch recanalization occurred more often (OR¼0.285, 95% CI 0.105-
0.771, P¼0.013). MACCE in hospital was compared between the two groups. The
33 to 53-month’s follow-up showed that patients in SR group didn’t have a better
prognosis evaluated by Kaplan-Meier curves (P¼0.162). Younger people, lower
levels of blood glucose, uric acid and low density lipoprotein, were independent
predictors of a better outcome (P<0.05), which were evaluated by cox proportional
hazards regression.
Conclusions: SR is not uncommon in STEMI patients. Biochemical indexes and
lesion features are closely associated with SR. STEMI patients can beneﬁt from SR in
a short time, no more than about 3 years. STEMI patients may beneﬁt from controlling
the levels of blood glucose, uric acid and low density lipoprotein.
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The preliminary research on the relationship of abnormal expressed microRNA-
21 of CD4+T lymphocyte and myocardial injury after percutaneous coronary
intervention in patients with acute coronary syndrome
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Objectives: To study the relationship of abnormal expressed microRNA-21 of
CD4+T lymphocyte and myocardial injury after percutaneous coronary intervention in
patients with acute coronary sysdrome. To provide insights into the effects of
microRNA-21 on myocardial injury in patients undergoing PCI.
Methods: A total of 41 individuals with UA, who presented to the cardiology
department of the First Afﬁliated Hospital of Gannan Medical University were
enrolled from September 2011 to December 2011 The patients were divided into two
groups based on their troponin I (TnI) levels; elevated TnI group (TnI>0.15ng/ml, 20
cases) and normal TnI group (TnI0.15ng/ml, 21cases). Eighteen normal control
subjects who were conﬁrmed by coronary angiography were enrolled in the study. The
level of microRNA-21 expression was measured by qRT-PCR before PCI and 12h
after PCI. The level of IFN-gRa protein expression were examined using western
blotting and the level of serum IFN-g and IL-4 were detected by ELISA before PCI
and 12h after PCI. Correlation analysis was made between microRNA-21 and the
level of IFN-gRa protein, serum IFN-g and IL-4.
Results: Compared with the control group, the expression of microRNA-21 and IFN-
g were signiﬁcantly increased (all P<0.01), and the level of IFN-gRa was markly
decreased in the elevated TnI group and the normal TnI group before PCI (all
P<0.01). There was no signiﬁcant different in the level of IL-4 between the three
groups before PCI (P>0.05). There was no signiﬁcant different in the expression of
microRNA-21, IFN-gRa and IFN-g between the elevated TnI group and the normal
TnI group before PCI (all P>0.01). The expressions of microRNA-155, hsCRP, IFN-
g were signiﬁcant increased, and the level of IFN-gRa protein was decreased in the
elevated TnI group and the normal TnI group at 12h after PCI (all P<0.05). The
changes were more obvious in the elevated TnI group than the normal TnI group (all
P<0.05). There was no signiﬁcant different in the level of IL-4 in the elevated TnI
group and the normal TnI group before and after PCI in. The expressions of miRNA-
155 were signiﬁcantly positive with IFN-g (r¼0.649, P<0.01; r¼0.682, P<0.01
respectively), and signiﬁcantly negative with IFN-gRa before and after PCI
(r¼-0.536, P<0.01; r¼-0.592, P<0.01, respectively). There was no correlation be-
tween microRNA-21 and IL-4 before and after PCI (r¼-0.165, P¼0.303; r¼0.107,
P¼0.506, respectively).9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
Conclusions: The evidence showed that abnormal expressed microRNA-21 of
CD4+T lymphocyte participated in the regulation process of Th2 cells differentiations,
and function. There was correlation between abnormal expressed microRNA-21 and
myocardial injury after PCI. MicroRNA-21 may involve in the immunoregulation
process of myocardial injury after PCI.
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Objectives: To investigate the effect of abnormal microRNA-21 expression on the
differentiations and functions CD4+ lymphocyte in patients with acute coronary
sysdrome.
Methods: Twenty patients with ACS were enrolled in the study. Blood samples were
taken from peripheral vein.The CD4+T lymphocyte were isolated from mononuclear
cells prepared with Ficoll-Hypaque density-gradients centrifugation from human pe-
ripheral blood by magnetic cell sorting system.The CD4+T cells were seeded in
culture plates of 6 wells.Each well contained 2ml RPMI-1640 medium without 10%
fetal bovine serum.There are four group CD4+T lymphocytes in the exper-
iment:control groups, microRNA-21groups, microRNA-21 inhibitor groups, and
FAM-siRNA groups.After stimulated with phytohemagglutinin, the CD4+T lym-
phocytes and culture supernatant were collected for the following experiments.The
frequencies of Th1 and Th2 cells were measured by ﬂow cytometry analysis
(FACS).The total RNA and protein were extracted from CD4+T lymphocytes using
Trizol and cell lysis buffer for western blotting, respectively.The level of IFN-gRa,
T-bet, GATA-3 mRNA expression were measured by qRT-PCR.The level of IFN-
gRa, T-bet, GATA-3 protein expression were examined using western blotting.The
productions of IFN-g and IL-4 in culture superatants of CD4+T lymphocytes were
detected by enzyme-linked immunosorbent assay (ELISA). Pearson correlation
analysis was conducted to examine the association between IFN-gRa and IFN-g,
IL-4.
Results: The FACS showed that microRNA-21 could promote CD4+T lymphocytes
to Th1 cells and the Th1 frequencies were also signiﬁcantly increased in microRNA-
21 group compared with the control group and miRNA-21 inhibitor group[(63.28.6)
% vs (47.210.3) %, P<0.01; (63.28.6) % vs (52.910.1) %, P¼0.024, respecti-
vely].There was no signiﬁcant difference between the three groups in the frequencies
of Th2 cells (F¼0.228, P¼0.798).In comparison with the control group, there was
signiﬁcant increase in the level of T-bet mRNA expression in miRNA-21 group
(P<0.01). The level of T-bet mRNA expression in microRNA-21 inhibitor group was
signiﬁcantly lower than that in microRNA-21 group (P<0.01). No signiﬁcant dif-
ferences were found between the three groups in the level of IFN-gRa and GATA-3
mRNA expression (F¼1.055, P¼0.362; F¼1.601, P¼0.220, respectively). The level
of IFN-gRa protein expression in microRNA-21 group was signiﬁcantly higher than
that in microRNA-21 group and microRNA-21 inhibitor group (all P<0.01). There
was no signiﬁcant difference between the three groups in the level of GATA-3 protein
expression (F¼0.098, P¼0.907.) The culture supernatant concentration of IFN-g in
microRNA-21 group was signiﬁcantly increased than that in the control group and
microRNA-21 inhibitor group (all P<0.01). No signiﬁcant difference was observed
between the three groups in the culture supernatant concentration of IL-4 (F¼0.384,
P¼0.685). There was signiﬁcant negatibe correlation between the protein expression
of IFN-gRa and the level of IFN-g. No signiﬁcant correlation were found between
IFN-gRa and IL-4.
Conclusions: It is evident that microRNA-21 can promote Th2 cells differentiations,
and thus improving the function, which partly attributed to inhibit the expression of
IFN-gRa protein and may play an important role in the pathogenesis of acute coronary
sysdrome.
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Correlation polymorphism of GDF-15 gene with the Acute Myocardial Infarction
(AMI) with early formation of collateral circulation
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Objectives: To explore the correlation polymorphism of -3148C/G site of GDF15
(Growth differentiation factor - 15) gene with the formation of collateral circulation of
Acute Myocardial Infarction (AMI) in Han people of Taiyuan area.
Methods: The polymerase chain reaction (PCR), gene sequencing and sequence
ﬂanking were used to detect and analyze the polymorphism of -3148C/G site of GDF-
15 gene for 92 ST-elevation myocardial infarction (STEMI) patients (Vascular oc-
clusion within 3-12 hours) with 68 collateral circulation group, 24 non-collateral
circulation group and 56 Patients with normal coronary angiography in a control
group.
Results: The genotype frequencies of CC, GC were 80.43% and 19.57% in the AMI
group, which were 60.71% and 39.29% in the control group respectively. P values of
the two groups at -3148C/G CC, GC genotype frequencies distribution is < 0.009.
The risk genotype GC, OR¼2.660, 95% of conﬁdent interval is 1.265- 5.595. And the
genotype frequencies of CC, GC were 85.29% and 14.71% in the AMI (Vascular
occlusion within 3-12 hours) collateral circulation group and 66.67% and 33.33% in
the AMI non- collateral circulation group individually, P values of two groups atJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/C-3148C/G CC, GC genotype frequencies distribution is <0.05; The risk genotype was
GC, OR¼2.900, 95% of conﬁdence interval is 0.983-8.556.
Conclusions: There is a correlation the polymorphism of -3148C/G site in GDF15
gene and the AMI (Vascular occlusion within 3-12 hours) patients with collateral
circulation in Ham people of Taiyuan area.
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Objectives: In our study we aimed to evaluate the effect of high-dose rosuvastatin
(HIGH-RSV) versus low-dose rosuvastatin (LOW-RSV) on NLRP3 and Cathepsin B
expression in peripheral blood monocytes in patients with acute coronary syndrome
(ACS).
Methods: Our study one hundred and twenty three subjects (123 subjects) whihch
included acute myocardial patients (AMI; n¼53), unstable angina patients (UA;
n¼40) and controls with no evidence of coronary artery disease (C; n¼30). Acute
myocardial infarction (AMI) and unstable angina (UA) were randomly devided into
high-dose rosuvastatin [HIGH-RSV (20mg)] or low-dose rosuvatatin [LOW-RSV
(5mg)] groups. Blood samples from each study subject were drawn at four time points
[at admission (w6 hours after chest pain and before statin administration), after 24-36
hours, after 1 week and after 4 weeks]. Blood was centrifuged and plasma was
separated. Monocytes were also isolated for further analysis. In plasma and mono-
cytes, NLRP3, Cathepsin B, Interleukin-18 (IL-18), Pro-Interleukin-18 (Pro-IL-18),
Interleukin-1b (IL-1b), Pro-Interleukin-1b (Pro-IL-1b), oxidized low density lipo-
protein (ox-LDL) expressions were appropriately evaluated with real time PCR, Flow
cytometry, Western blot and Elisa. Concentrations of serum inﬂammatory markers
were also evaluated for correlation with NLRP3.
Results: At baseline, acute myocardial infarction (AMI) and unstable infarction (UA)
patients had higher NLRP3, Cathepsin-b, IL-18 Pro-IL18, IL-1b and Pro-IL1b
expression in circulating monocytes as compared with control group (P<0.05). This
corresponded with higher levels of serum total cholesterol, serum LDL cholesterol and
ox-LDL in unstable angina (UA) and Acute myocardial infarction (AMI) patients
(P<0.05). High dose of rosuvastatin (20mg) caused signiﬁcantly stronger (P<0.05)
changes in NLRP3, Cathepsin B and their downstream cytokines as compared to low
dose of rosuvastatin (P>0.05) from baseline to the fourth time point after 4 weeks.
Our results also showed positive correlation between NLRP3, Cathepsin-b and other
inﬂammatory mediators.
Conclusions: Circulating monocytes in acute coronary syndrome (ACS) had a higher
expression of NLRP3, Cathepsin B, and their downstream cytokines. Moreover, we
demonstrated that in ACS patiens there was good correlation between NLRP3 and
Catherpsin B. We also showed that high dose of statin had a more pronounced and
desirable effect on the dynamic changes of NLRP3, Cathepsin B, their downstream
mediators. These ﬁndings add new insights to the pathogenesis and management of
ACS with NLRP3 as the potential target.
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Association of the neutrophil–lymphocyte ratio (NLR) with outcomes in patients
admitted for an acute coronary syndrome
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Objectives: Patients with documented acute coronary syndromes or ACS exhibit a
wide spectrum of early risk of death, ranging from 1 to 10%. An elevated leukocyte
count has been identiﬁed as an independent predictor of an increased risk for long-
term mortality and myocardial infarction. An elevated neutrophil count predicts a
worse outcome in ACS. In contrast, a low lymphocyte count is related to high risks
of adverse outcomes and mechanical complications, low ejection fraction, high
degree of myocardial necrosis and mortality in patients with ACS. The neutrophil-
lymphocyte ratio (NLR), therefore, integrates for two WBC subtypes with opposite
actions in terms of vascular inﬂammation. Among patients diagnosed with ACS in
the Philippine General Hospital, we aim to determine if an elevated NLR taken
within 24 hours of admission is associated with higher rates of cardiovascular
morbidities & mortalities.
Methods: A prospective cohort of adult patients admitted with a diagnosis of ACS
(unstable angina, NSTEMI, STEMI) was conducted. The participants were stratiﬁed
into two groups: low to intermediate NLR (NLR  6.5) and high NLR (NLR > 6.50).
The primary outcome was in-hospital mortality. Secondary outcomes include devel-
opment or worsening of congestive heart failure (CHF) and the development of
cardiogenic shock, re-infarction, dialysis-requiring renal failure, high-risk pneumonia,
and arrhythmias.
Results: 117 patients with a mean age of 60 +/- 13 were included. Majority had 1-4
traditional risk factors for ACS. Diagnosis on admission was unstable angina (28%),
NSTEMI (40%), and STEMI (37%). Analysis of data showed that the odds of in-
hospital deaths among those with a high NLR is 5.71 times higher compared to those
with low-intermediate NLR [OR 5.71 (1.53-21.23, p 0.009)]. Using linear regression,
the NLR of patients who were non-survivors was computed at 9.91, while the NLR of
those who survived was 5.47. A high NLR was also predictive of the development or
worsening of CHF [OR 4.75 (1.47 – 15.3, p 0.009), shock [OR 5.0 (1.97 – 12.67,ardiovascular Disease Clinical Research C135
